CytoSorbents Corp (CTSO): Market Cap to Revenue

Symbol and logo of brand CytoSorbents Corp. (CTSO)

Cytosorbents is successfully implementing unique sorption filters, avoiding dumping through technological superiority. The company's P/S ratio confirms this trend, with the value holding at 0.50. Growth is based on the expansion of B2B sales of CytoSorb systems in clinics. High authority among surgeons and a track record of saving patients with sepsis solidify its status as a global leader in blood purification.

CTSO CytoSorbents Corp. P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Cytosorbents (CTSO)

- share price and consensus valuation forecast:
Price Performance Chart cytosorbents.com|CTSO - Price Target Chart
- stock exchange capitalization data:
Market Valuation CytoSorbents Corp.|CTSO - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Cytosorbents|CTSO - Book Capitalization|Capitalization to Book Value Ratio cytosorbents.com|CTSO - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Cytosorbents|CTSO - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio cytosorbents.com|CTSO - Company Aggregate Debts|Debts to Book Capitalization CytoSorbents Corp.|CTSO - Company Long-Term Debt|Company Short-Term Debt Cytosorbents|Intermediate Coverage Ratio cytosorbents.com
- earnings and multiples data:
CTSO - Net Profit|Expected Net Profit Cytosorbents|CTSO - Price to Earnings Ratio|Forward Price to Earnings Multiple cytosorbents.com|CTSO - Price/Earnings to Growth Multiple|EV/EBITDA Multiple CytoSorbents Corp.|CTSO - Operating profit EBITDA|Net earnings per share for the last four quarters Cytosorbents|CTSO - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months cytosorbents.com|CTSO - Earnings per share growth in current year|Expected earnings per share growth for next year Cytosorbents
- issuer revenue and sales details:
CTSO - Revenue and Sales Volume|Company Expected Sales Volume cytosorbents.com|CTSO - Price-to-Revenue Ratio|Market Cap to Projected Revenue CytoSorbents Corp.
General company analysis:CTSO CytoSorbents Corp
Core merchandise of CytoSorbents Corporation

Assessing the investment potential of Cytosorbents (CTSO) requires an analysis of the ratio between market value and actual cash flows. This price-to-sales ratio measures capitalization per unit of sales, allowing for the identification of asset overheating. In the context of CytoSorb technology maturity, this metric reflects the monetization efficiency of blood purification systems. The indicator's dynamics help investors compare the pace of expansion into new niches with current market expectations.

Competitors of Cytosorbents

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA: P/S Multiple|Market Cap to Revenue STRATA Skin Sciences, Inc.|Market Cap to Revenue GCTK|Price to Sales nanovibronix.com NAOV|Market Cap to Revenue VERO (Venus Concept Corp)|Market Cap to Sales Volume NUWE|Price-to-Revenue Ratio Aethlon Medical AEMD|Asensus Surgical Inc (ASXC) - Price to Sales|AVGR - Price-to-Revenue Ratio|Price-to-Revenue Coefficient BioSig BSGM|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|Price to Sales Know Labs Corporation (KNW)|Price-to-Revenue Ratio Inari Medical, Inc.|NVRO: Market Capitalization-to-Revenue Ratio|P/S Multiple RSLS|Price-to-Revenue Ratio SILK (Silk Road Medical, Inc.)